This research service presents an analysis of selected infectious disease IVD in the APAC market. The study is segmented based on the following three main methods of diagnostic technologies used: microbiology testing, immunochemistry, and molecular diagnostics. It provides in-depth analysis of infectious diseases with higher occurrence in the Asia-Pacific market, namely malaria, dengue, tuberculosis, sexually transmitted infections, hepatitis C, influenza, and pertussis. It provides an in-depth analysis of revenue forecast by segment, drivers and restraints, technology trends, and strategies for Australia, South Korea, Malaysia, Thailand, Indonesia, the Philippines, and Vietnam.